
Meftik 250mg Injection
Marketer
Mefro Pharmaceuticals Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Meftik 250mg Injection
Ceftiofur 250mg injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, skeletal system, lungs (such as pneumonia), central nervous system, and bloodstream. This antibiotic is also prophylactically administered to hospitalized individuals to reduce infection risk. Its mechanism involves bacterial growth inhibition. Administered intravenously via infusion or direct injection (intramuscular or intravenous) by a healthcare professional only, it requires adherence to a prescribed dosage schedule. Consistent, evenly spaced doses are crucial; premature cessation can result in relapse or infection exacerbation. Typical adverse effects include injection site reactions and elevated blood urea nitrogen levels. Persistent side effects or treatment inefficacy warrant medical consultation. High dosages may induce vertigo, nephrotoxicity, and ototoxicity. Close monitoring, potentially including renal function, audiological, and urinalysis assessments, may be implemented. This medication is contraindicated during gestation. Disclose pregnancy, pregnancy intentions, or lactation to your physician.
Uses of Meftik 250mg Injection
Infections caused by bacteria
Major Benefits of Meftik 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Meftik 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Meftik 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
How Meftik 250mg Injection works:
Meftik 250mg Injection is a bacterial infection medication. Its mechanism of action involves inhibiting the production of crucial bacterial proteins, thus halting bacterial proliferation.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using Meftik 250mg Injection concurrently with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Meftik 250mg Injection during gestation poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
Administration of Meftik 250mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Administering Meftik 250mg Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Meftik 250mg Injection, as dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Meftik 250mg Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dosage modification for Meftik 250mg Injection might be unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Meftik 250mg Injection :
Should you forget a scheduled dose of Meftik 250mg Injection, seek your physician's advice.
Facts to Know About Meftik 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
